Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Bickel

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
NIDA Research Monograph|January 1, 1995
Vector-mediated delivery of opioid peptides to the brainU Bickel, W M Pardridge
Journal of Drug Targeting|May 1, 2001
Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cellsY S Kang, K Voigt, U Bickel
Advanced Drug Delivery Reviews|March 22, 2001
Delivery of peptides and proteins through the blood-brain barrierU Bickel, T Yoshikawa, W M Pardridge
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Synthesis and bioactivity of monobiotinylated DALDA: a mu-specific opioid peptide designed for targeted brain deliveryU Bickel, S Yamada, W M Pardridge
Bioconjugate Chemistry|March 1, 1995
In vivo cleavability of a disulfide-based chimeric opioid peptide in rat brainU Bickel, Y S Kang, W M Pardridge
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1994
Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptorY S Kang, U Bickel, W M Pardridge
The American Journal of Physiology|July 1, 1994
Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogueA Samii, U Bickel, U Stroth, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humansT Thomsen, U Bickel, J P Fischer, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Fluocortolone: pharmacokinetics and effect on ACTH and cortisol secretion during daily and alternate-day administrationU Tüber, U Posern, U Bickel, et al.
Pharmacogenetics|January 14, 2000
The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6R Bachus, U Bickel, T Thomsen, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
NIDA Research Monograph|January 1, 1995
Vector-mediated delivery of opioid peptides to the brainU Bickel, W M Pardridge
Journal of Drug Targeting|May 1, 2001
Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cellsY S Kang, K Voigt, U Bickel
Advanced Drug Delivery Reviews|March 22, 2001
Delivery of peptides and proteins through the blood-brain barrierU Bickel, T Yoshikawa, W M Pardridge
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Synthesis and bioactivity of monobiotinylated DALDA: a mu-specific opioid peptide designed for targeted brain deliveryU Bickel, S Yamada, W M Pardridge
Bioconjugate Chemistry|March 1, 1995
In vivo cleavability of a disulfide-based chimeric opioid peptide in rat brainU Bickel, Y S Kang, W M Pardridge
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1994
Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptorY S Kang, U Bickel, W M Pardridge
The American Journal of Physiology|July 1, 1994
Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogueA Samii, U Bickel, U Stroth, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humansT Thomsen, U Bickel, J P Fischer, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Fluocortolone: pharmacokinetics and effect on ACTH and cortisol secretion during daily and alternate-day administrationU Tüber, U Posern, U Bickel, et al.
Pharmacogenetics|January 14, 2000
The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6R Bachus, U Bickel, T Thomsen, et al.
Pageof 4